By Alex Philippidis

NEW YORK (GenomeWeb News) — Officials in Peoria, Ariz., Tuesday agreed to commit $200,000 over two years to a partnership focused on commercializing life-sciences discoveries, with the city set to work with Translational Genomics Research Institute and possibly other partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.